![Kjell Göran Stenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kjell Göran Stenberg
Directeur Général chez
CYXONE AB
Profil
Kjell Göran Stenberg is the founder of Combio A, which was founded in 1975.
He held the title of Chief Executive Officer at Combio A. He currently holds the position of Chief Executive Officer & Director at Accequa AB, Celus Pharmaceuticals Ltd., and Cyxone AB. He also serves as the Director at iNotify ApS and is the Owner of Biomedical Development Europe.
In the past, Dr. Stenberg served as the Chief Executive Officer of Cyxone AB from 2015 to 2019.
He was also the Chairman of Aptahem AB from 2018 to 2020.
Additionally, he held the role of Chief Operating Officer & Director at Medwell Capital Corp.
from 2005 to 2010.
He served as a Director at PCI Biotech Holding ASA from 2013 to 2015 and at Galecto Biotech ApS from 2013 to 2019.
Prior to that, he worked at Astra AB and AstraZeneca AB as a Manager & Senior Researcher from 1975 to 2000.
Dr. Stenberg obtained a doctorate degree from Karolinska Institutet and a graduate degree from Umea Universitet.
Postes actifs de Kjell Göran Stenberg
| Sociétés | Poste | Début |
|---|---|---|
| CYXONE AB | Directeur Général | 01/01/2024 |
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology research and development company | Directeur/Membre du Conseil | 01/11/2009 |
Biomedical Development Europe | Corporate Officer/Principal | - |
Celus Pharmaceuticals Ltd. | Directeur Général | - |
Anciens postes connus de Kjell Göran Stenberg
| Sociétés | Poste | Fin |
|---|---|---|
Accequa AB | Directeur Général | 22/06/2025 |
| APTAHEM AB | Président | 03/09/2020 |
| CYXONE AB | Directeur Général | 13/11/2019 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Président | 01/05/2013 |
| PCI BIOTECH HOLDING ASA | Directeur/Membre du Conseil | 01/05/2015 |
Formation de Kjell Göran Stenberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations | Health Technology |
Medwell Capital Corp.
 Medwell Capital Corp. Investment ManagersFinance Operates as a investment and healthcare advisory firm | Finance |
PCI Biotech Holding ASA
 PCI Biotech Holding ASA BiotechnologyHealth Technology Develops photochemical drug delivery technology for use in therapeutic treatment | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novation Pharmaceuticals, Inc.
Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology research and development company | Health Services |
Combio A/S | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Accequa AB | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Engages in the pharmaceutical businesses, which research and develops medicines for treating and preventing diseases caused by blockage of blood vessels, such as deep vein thrombosis, stroke and heart failure | Health Technology |
Biomedical Development Europe | |
Cyxone AB
 Cyxone AB Pharmaceuticals: MajorHealth Technology Develops cyclotide drugs for autoimmune and other diseases | Health Technology |
Celus Pharmaceuticals Ltd. |
